An early ISIA objective has been to assist customers around the world in comparing quality and physiochemical analyses of different batches of serum, or different regulatory specifications.
As early as 2007, a questionnaire was distributed to all ISIA members to develop an industry wide view of quality control testing. Data was analyzed and a white paper developed to define those tests and documentation where standardization will allow the industry to serve the customer better and in a less confusing manner. A proposal for a standardized Certificate of Analysis was formulated.
In 2017, the questionnaire was revisited and the quality control matrix was updated.